Association of aldehyde dehydrogenase 1 expression and biologically aggressive features in breast cancer

Neoplasma

Volumn 61, Issue 3, 2014, Pages 352-362

  Kang, E J ^a   Jung, H ^b   Woo, O H ^a   Park, K H ^a   Woo, S U ^a   Yang, D S ^a   Kim, A R ^a   Lee, J B ^a   Kim, Y H ^a   Kim, J S ^a   Seo, J H ^a  

^a Korea University   (South Korea)

^b Catholic Kwandong University   (South Korea)

Author keywords

ALDH1; Biologically aggressive; Breast cancer

Indexed keywords

ALDEHYDE DEHYDROGENASE; KI 67 ANTIGEN; PROTEIN P53; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BREAST CANCER; DISEASE FREE SURVIVAL; EVALUATION AND FOLLOW UP; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PHENOTYPE; PROTEIN EXPRESSION; TISSUE MICROARRAY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; ISOENZYMES; MIDDLE AGED; RECEPTORS, ESTROGEN; RETINAL DEHYDROGENASE; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS;

EID: 84902332685     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2014_045     Document Type: Article

References (34)

1. MARSDEN CG, WRIGHT MJ, POCHAMPALLY R, ROWAN BG. Breast tumor-initiating cells isolated from patient core biopsies for study of hormone action. Methods Mol Biol 2009; 590: 363-375. http://dx.doi.org/10.1007/978-1-60327-378- 7_23
2. LAPIDOT T, SIRARD C, VORMOOR J, MURDOCH B, HOANG T et al. A cell initiating human acute myeloid leu- kaemia afer transplantation into SCID mice. Nature 1994; 367: 645-648. http://dx.doi.org/10.1038/367645a0
3. KIM CF, JACKSON EL, WOOLFENDEN AE, LAWRENCE S, BABAR I et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823-835. http://dx.doi.org/10.1016/j.cell.2005.03.032
4. SINGH SK, HAWKINS C, CLARKE ID, SQUIRE JA, BAYANI J et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401. http://dx.doi.org/10.1038/ nature03128
5. Al-Hajj M, WICHA MS, Benito-Hernandez A, MORRISON SJ, CLARKE MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-3988. http://dx.doi.org/10.1073/pnas.0530291100
6. GINESTIER C, HUR MH, Charafe-Jauffret E, Mon-Ville F, DUTCHER J et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567. http://dx.doi.org/10.1016/j.stem.2007.08.014
7. SOPHOS NA, VASILIOU V. Aldehyde dehydrogenase gene superfamily: the 2002 update. Chem Biol Interact 2003; 143-144: 5-22. http://dx.doi.org/10.1016/S0009- 2797(02)00163-1
8. DUESTER G, MIC FA, MOLOTKOV A. Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid. Chem Biol Interact 2003; 143-144: 201-210. http://dx.doi.org/10.1016/S0009-2797(02)00204-1
9. LI F, TIEDE B, MASSAGUE J, KANG Y. Beyond tumorigen- esis: cancer stem cells in metastasis. Cell Res 2007; 17: 3-14. http://dx.doi.org/10.1038/sj.cr.7310118
10. PERONA R, Lopez-Ayllon BD, De Castro Carpeno J, Belda-Iniesta C. A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer. Clin Transl Oncol 2011; 13: 289-293. http://dx.doi.org/10.1007/ s12094-011-0656-3
11. MORIMOTO K, KIM SJ, TANEI T, SHIMAZU K, TANJI Y et al. Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen recep- tor, positive human epidermal growth factor receptor type 2, and high Ki67 expression. Cancer Sci 2009; 100: 1062-1068. http://dx.doi.org/10.1111/j.1349-7006.2009.01151.x
12. NALWOGA H, ARNES JB, WABINGA H, AKSLEN LA. Ex- pression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer. Br J Cancer 2010; 102: 369-375. http://dx.doi.org/10.1038/sj.bjc.6605488
13. Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatorybreast cancer. Clin Cancer Res 2010; 16: 45-55. http://dx.doi.org/10.1158/1078-0432.CCR-09-1630
14. OHI Y, UMEKITA Y, YOSHIOKA T, SOUDA M, RAI Y et al. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer. Histopathology 2011; 59: 776-780. http://dx.doi.org/10.1111/j.1365-2559.2011.03884. x
15. YOSHIOKA T, UMEKITA Y, OHI Y, SOUDA M, SAGARA Y et al. Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study. Histopathology 2011; 58: 608-616. http:// dx.doi.org/10.1111/j.1365-2559.2011.03781.x
16. LEE HE, KIM JH, KIM YJ, CHOI SY, KIM SW et al. An increase in cancer stem cell population afer primary sys- temic therapy is a poor prognostic factor in breast cancer. Br J Cancer 2011; 104: 1730-1738. http://dx.doi.org/10.1038/ bjc.2011.159
17. TANEI T, MORIMOTO K, SHIMAZU K, KIM SJ, TANJI Y et al. Association of breast cancer stem cells identified by alde- hyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res 2009; 15: 4234-4241. http://dx.doi. org/10.1158/1078-0432.CCR-08-1479
18. ANTONELLI M, BUTTARELLI FR, ARCELLA A, NOBU- SAWA S, DONOFRIO V et al. Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas. J Neurooncol 2010; 99: 209-215. http://dx.doi.org/10.1007/s11060-010-0129-5
19. SHAO R, CAO QJ, ARENAS RB, BIGELOW C, BENTLEY B et al. Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers. Br J Cancer 2011; 105: 1203-1209. http://dx.doi.org/10.1038/ bjc.2011.347
20. TEN HAAF A, BEKTAS N, VON SERENYI S, LOSEN I, ARWEILER EC et al. Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associ-ated with unfavourable overall survival. BMC Cancer 2009; 9: 298. http://dx.doi.org/10.1186/1471-2407-9-298
21. KHAMIS ZI, SAHAB ZJ, SANG QX. Active roles of tumor stroma in breast cancer metastasis. Int J Breast Cancer 2012; 2012: 574025. http://dx.doi.org/10.1155/2012/574025
22. WOLFF AC, HAMMOND ME, SCHWARTZ JN, HAGER-TY KL, ALLRED DC et al. American Society of Clinical Oncology/College of American Pathologists guideline rec-ommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 2007; 131: 18-43.
23. JUNG KW, PARK S, KONG HJ, WON YJ, LEE JY et al. Cancer statistics in Korea: incidence, mortality, survival, and preva- lence in 2009. Cancer Res Treat 2012; 44: 11-24. http://dx.doi. org/10.4143/crt.2012.44.1.11
24. HEERMA VAN VOSS MR, VAN DER GROEP P, BART J, VAN DER WALL E, VAN DIEST PJ. Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer. Cell Oncol (Dordr) 2011; 34: 3-10. http://dx.doi.org/10.1007/s13402- 010-0007-3
25. RESETKOVA E, Reis-Filho JS, JAIN RK, MEHTA R, THORAT MA et al. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat 2010; 123: 97-108. http://dx.doi. org/10.1007/s10549-009-0619-3
26. TAN EY, THIKE AA, TAN PH. ALDH1 expression is enriched in breast cancers arising in young women but does not pre-dict outcome. Br J Cancer 2013; 109: 109-113. http://dx.doi. org/10.1038/bjc.2013.297
27. ASSI HA, KHOURY KE, DBOUK H, KHALIL LE, MOUHIEDDINE TH et al. Epidemiology and prognosis of breast cancer in young women. J Torac Dis 2013; 5: S2-8.
28. DE BECA FF, CAETANO P, GERHARD R, ALVARENGA CA, GOMES M et al. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types. J Clin Pathol 2013; 66: 187-191. http://dx.doi.org/10.1136/jclinpath- 2012-201169
29. NOGAMI T, SHIEN T, TANAKA T, NISHIYAMA K, MI-Zoo T et al. Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases. Breast Cancer 2012.
30. SAKAKIBARA M, FUJIMORI T, MIYOSHI T, NAGASHIMA T, FUJIMOTO H et al. Aldehyde dehydrogenase 1-positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with lymph node-positive breast cancer. Cancer 2012; 118: 3899-3910. http://dx.doi. org/10.1002/cncr.26725
31. ISFOSS BL, HOLMQVIST B, ALM P, OLSSON H. Distribu-tion of aldehyde dehydrogenase 1-positive stem cells in benign mammary tissue from women with and without breast cancer. Histopathology 2012; 60: 617-633. http://dx.doi.org/10.1111/ j.1365-2559.2011.04109.x
32. KUNJU LP, COOKINGHAM C, TOY KA, CHEN W, SABEL MS et al. EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development. Mod Pathol 2011; 24: 786-793. http://dx.doi.org/10.1038/modpathol.2011.8
33. PITTERI SJ, Kelly-Spratt KS, GURLEY KE, KENNEDY J, BUSON TB et al. Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression. Cancer Res 2011; 71: 5090-5100. http://dx.doi.org/10.1158/0008-5472.CAN-11-0568
34. De Brot M, ROCHA RM, SOARES FA, GOBBI H. Prog-nostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers. Pathology 2012; 44: 303-312. http://dx.doi.org/10.1097/ PAT.0b013e3283534bcb